MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical Announces Top Management Change SHENZHEN, China, November 5, 2012 /PRNewswire-FirstCall/ — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang, has resigned from his co-chief executive officer (co-CEO) position, effective immediately, but will continue to serve as Mindray’s chairman. Mr. Li Xiting, Mindray’s president and]

By | 2016-03-04T06:20:29+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: Mindray Medical Announces Top Management Change SHENZHEN, China,

[Mindray Medical Announces Top Management Change SHENZHEN, China, November 5, 2012 /PRNewswire-FirstCall/ — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang, has resigned from his co-chief executive officer (co-CEO) position, effective immediately, but will continue to serve as Mindray’s chairman. Mr. Li Xiting, Mindray’s president and]

By | 2016-03-04T06:23:55+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Third Quarter 2012 Financial Results Shenzhen, China – November 5, 2012 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2012. Highlights for Third Quarter 2012 • Net revenues were $257.1 million, up 17.7% over the]

By | 2016-03-04T06:15:47+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: Mindray Announces Third Quarter 2012 Financial Results Shenzhen,

[Mindray Announces Third Quarter 2012 Financial Results Shenzhen, China – November 5, 2012 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2012. Highlights for Third Quarter 2012 • Net revenues were $257.1 million, up 17.7% over the]

By | 2016-03-04T06:17:22+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical Announces Top Management Change STYLE="font-family:Times New Roman" SIZE="2"> SHENZHEN, China,November 5, 2012/PRNewswire-FirstCall/ Mindray Medical International Limited(NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang, has resigned from his-chief executive officer (co-CEO) position, effective immediately, but willntinue to serve Mindrays chairman. Mr.Li Xiting, Mindrays president]

By | 2016-02-08T04:38:37+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: Mindray Medical Announces Top Management Change STYLE=”font-family:Times New

[Mindray Medical Announces Top Management Change STYLE="font-family:Times New Roman" SIZE="2"> SHENZHEN, China,November 5, 2012/PRNewswire-FirstCall/ Mindray Medical International Limited(NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang, has resigned from his-chief executive officer (co-CEO) position, effective immediately, but willntinue to serve Mindrays chairman. Mr.Li Xiting, Mindrays president]

By | 2016-02-08T04:39:31+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: Mindray Announces Third Quarter 2012 Financial Results STYLE=”font-family:Times

[Mindray Announces Third Quarter 2012 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China November5, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2012. Highlights for Third Quarter 2012 Net revenues were $257.1 million,]

By | 2016-02-08T04:37:40+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Third Quarter 2012 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China November5, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2012. Highlights for Third Quarter 2012 Net revenues were $257.1 million,]

By | 2016-02-08T04:36:48+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: Mindray Medical Announces Top Management Change SHENZHEN, China,November

[Mindray Medical Announces Top Management Change SHENZHEN, China,November 5, 2012/PRNewswire-FirstCall/ Mindray Medical International Limited(NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang, has resigned from his-chief executive officer (co-CEO) position, effective immediately, but willntinue to serve Mindrays chairman. Mr.Li Xiting, Mindrays president and-CEO, has been appointed]

By | 2016-01-13T10:40:12+00:00 November 5th, 2012|Categories: Chinese Stocks, MR, Webplus ver|Tags: , , , , , |0 Comments
Read More

PTR [PETROCHINA CO] CORRESP: (Original Filing)

[November 5, 2012 H. Roger Schwall Jennifer O’Brien Ethan Horowitz Division of Corporate Finance 100 F Street, NE Re: PetroChina Company Limited Form 20-F for Fiscal Year Ended December 31, 2011 Filed April 26, 2012 Response Letter Dated September 21, 2012 File No. 001-15006 Dear Mr. Schwall, Ms. O’Brien and Mr. Horowitz: Set forth below are the Company’s responses to]

By | 2016-03-28T21:35:36+00:00 November 5th, 2012|Categories: Chinese Stocks, PTR, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar